Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

The Oncology Institute Q1 EPS $(0.22) Misses $(0.12) Estimate, Sales $94.67M Miss $95.16M Estimate

Author: Benzinga Newsdesk | May 14, 2024 04:19pm
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 33.33 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $94.67 million which missed the analyst consensus estimate of $95.16 million by 0.52 percent. This is a 24.25 percent increase over sales of $76.19 million the same period last year.

Posted In: TOI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist